BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33307330)

  • 1. Sex differences in risk factors for white matter hyperintensities in non-demented older individuals.
    Alqarni A; Jiang J; Crawford JD; Koch F; Brodaty H; Sachdev P; Wen W
    Neurobiol Aging; 2021 Feb; 98():197-204. PubMed ID: 33307330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative MRI of cerebral white matter hyperintensities: A new approach towards understanding the underlying pathology.
    Iordanishvili E; Schall M; Loução R; Zimmermann M; Kotetishvili K; Shah NJ; Oros-Peusquens AM
    Neuroimage; 2019 Nov; 202():116077. PubMed ID: 31398433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral white matter hyperintensities (WMH): an analysis of cerebrovascular risk factors in Lebanon.
    Gebeily S; Fares Y; Kordahi M; Khodeir P; Labaki G; Fazekas F
    Int J Neurosci; 2014 Nov; 124(11):799-805. PubMed ID: 24433122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.
    Armstrong NJ; Mather KA; Sargurupremraj M; Knol MJ; Malik R; Satizabal CL; Yanek LR; Wen W; Gudnason VG; Dueker ND; Elliott LT; Hofer E; Bis J; Jahanshad N; Li S; Logue MA; Luciano M; Scholz M; Smith AV; Trompet S; Vojinovic D; Xia R; Alfaro-Almagro F; Ames D; Amin N; Amouyel P; Beiser AS; Brodaty H; Deary IJ; Fennema-Notestine C; Gampawar PG; Gottesman R; Griffanti L; Jack CR; Jenkinson M; Jiang J; Kral BG; Kwok JB; Lampe L; C M Liewald D; Maillard P; Marchini J; Bastin ME; Mazoyer B; Pirpamer L; Rafael Romero J; Roshchupkin GV; Schofield PR; Schroeter ML; Stott DJ; Thalamuthu A; Trollor J; Tzourio C; van der Grond J; Vernooij MW; Witte VA; Wright MJ; Yang Q; Morris Z; Siggurdsson S; Psaty B; Villringer A; Schmidt H; Haberg AK; van Duijn CM; Jukema JW; Dichgans M; Sacco RL; Wright CB; Kremen WS; Becker LC; Thompson PM; Mosley TH; Wardlaw JM; Ikram MA; Adams HHH; Seshadri S; Sachdev PS; Smith SM; Launer L; Longstreth W; DeCarli C; Schmidt R; Fornage M; Debette S; Nyquist PA
    Stroke; 2020 Jul; 51(7):2111-2121. PubMed ID: 32517579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesion location matters: The relationships between white matter hyperintensities on cognition in the healthy elderly.
    Lampe L; Kharabian-Masouleh S; Kynast J; Arelin K; Steele CJ; Löffler M; Witte AV; Schroeter ML; Villringer A; Bazin PL
    J Cereb Blood Flow Metab; 2019 Jan; 39(1):36-43. PubMed ID: 29106319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational quantification of brain perivascular space morphologies: Associations with vascular risk factors and white matter hyperintensities. A study in the Lothian Birth Cohort 1936.
    Ballerini L; Booth T; Valdés Hernández MDC; Wiseman S; Lovreglio R; Muñoz Maniega S; Morris Z; Pattie A; Corley J; Gow A; Bastin ME; Deary IJ; Wardlaw J
    Neuroimage Clin; 2020; 25():102120. PubMed ID: 31887717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Hyperintensities Are Under Strong Genetic Influence.
    Sachdev PS; Thalamuthu A; Mather KA; Ames D; Wright MJ; Wen W;
    Stroke; 2016 Jun; 47(6):1422-8. PubMed ID: 27165950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral obesity is associated with white matter hyperintensity and lacunar infarct.
    Kim KW; Seo H; Kwak MS; Kim D
    Int J Obes (Lond); 2017 May; 41(5):683-688. PubMed ID: 28104915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation Between Sex, Menopause, and White Matter Hyperintensities: The Rhineland Study.
    Lohner V; Pehlivan G; Sanroma G; Miloschewski A; Schirmer MD; Stöcker T; Reuter M; Breteler MMB
    Neurology; 2022 Aug; 99(9):e935-e943. PubMed ID: 35768207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strictly Lobar Cerebral Microbleeds Are Associated with Increased White Matter Volume.
    Wang PN; Chou KH; Peng LN; Liu LK; Lee WJ; Chen LK; Lin CP; Chung CP
    Transl Stroke Res; 2020 Feb; 11(1):29-38. PubMed ID: 31037565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural Substrates of Psychomotor Speed Deficits in Cerebral Small Vessel Disease: A Brain Disconnectome Mapping Study.
    da Silva PHR; de Leeuw FE; Zotin MCZ; Neto OMP; Leoni RF; Tuladhar AM
    Brain Topogr; 2023 Jul; 36(4):545-553. PubMed ID: 37156893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.
    Swardfager W; Yu D; Scola G; Cogo-Moreira H; Chan P; Zou Y; Herrmann N; Lanctôt KL; Ramirez J; Gao F; Masellis M; Swartz RH; Sahlas DJ; Chan PC; Ojeda-Lopez C; Milan-Tomas A; Pettersen JA; Andreazza AC; Black SE
    Neurobiol Aging; 2017 Nov; 59():91-97. PubMed ID: 28756941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial Pulsatility in Relation to Severity and Progression of Cerebral White Matter Hyperintensities.
    Kneihsl M; Hofer E; Enzinger C; Niederkorn K; Horner S; Pinter D; Fandler-Höfler S; Eppinger S; Haidegger M; Schmidt R; Gattringer T
    Stroke; 2020 Nov; 51(11):3302-3309. PubMed ID: 32883195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
    Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
    AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.
    Scott JA; Braskie MN; Tosun D; Maillard P; Thompson PM; Weiner M; DeCarli C; Carmichael OT;
    Neurobiol Aging; 2016 Dec; 48():48-52. PubMed ID: 27639120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up.
    Cai M; Jacob MA; van Loenen MR; Bergkamp M; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Sep; 53(9):2789-2798. PubMed ID: 35506383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.